A new year - new opportunities

February 6, 2012

With a fresh new year ahead of us, we want to recap on some of the most important events of last year, as well as share with you our ambitions for the year to come.

2011 - a year to remember

2011 was in many ways a landmark in the Uniferon history marked among other things by our launch on the US market with the approval of the FDA in July. A truly important stepping-stone in our global Uniferon endeavors.

2011 was also the year where we could welcome a large group of new Partners to the Uniferon "family", including Germany, Holland, Spain, Portugal, Serbia, Russia, Denmark, Norway, Iceland, Sweden and Finland. It is great feeling knowing that we have a competent and dedicated group of Partners worldwide joining the efforts in making Uniferon the no. 1 iron supplementation in the world.

The preceding year saw many new initiatives that we are genuinely proud of, not least the Iron Weight/Gain Optimizer, which is found right here on uniferon.com. If you have not yet tried the online simulator, we encourage you to have a go and learn for yourself how this exciting tool can provide a deeper understanding of the relationship between iron and growth.

2012 - an exciting year to come

Our visions for 2012 are clear. We want to continue our efforts in making Uniferon available for pig farmers and continue making Uniferon the easy and clever choice for clever breeders. There are exciting challenges ahead of us and we are bursting with motivation to continue our work with quality iron supplementation.

In 2012 Pharmacosmos and Uniferon will be present at both the IPVS and the AASV in March, where we will address issues of importance to representatives from the American pig industry. And we look forward to seeing many of you out there "in the real world" in 2012.

About Uniferon

Uniferon is a modern improved iron hydrogenated dextran based on a natural formula, which is approved for global use:

Uniferon is manufactured without the use of any organic solvents or cyanide, thus, avoiding trace residues of these impurities. Pharmacosmos manufactures iron dextran of high quality and unique purity for customers worldwide. Uniferon is the only injectable iron brand for piglets approved in the EU, the US and Asia.

About Pharmacosmos

Headquartered in Denmark, Pharmacosmos is a family-owned, international healthcare company with more than 50 years of innovation and leadership in iron- and carbohydrate-based treatments and solutions for human and animal use.

A research-based company, its ongoing R&D programme focuses on improving the lives of patients with iron deficiency with or without anaemia. More than 1 billion people live with iron deficiency anaemia and it is the leading cause of death for an estimated 180,000 people every year. This makes it one of the largest global health challenges of our time.

Pharmacosmos has subsidiaries in the Nordics, the UK and the US and its products are marketed in more than 80 countries across the world. Its manufacturing facilities are approved, among others, by the Danish Medicines Agency and the US FDA.